ClinConnect ClinConnect Logo
Search / Trial NCT01171911

Comparison of Intravenous Injection of Calcium Antagonist and Beta-blockade on Endothelial Shear Stress of Coronary Artery

Launched by NANJING MEDICAL UNIVERSITY · Jul 28, 2010

Trial Information

Current as of August 11, 2025

Unknown status

Keywords

Endothelial Shear Stress Calcium Channel Blocker

ClinConnect Summary

Blood flow-induced endothelial shear stress has strong effect on endothelial function and development or progression of plaque formation. It is extensively accepted that low and/or oscillating shear stress causes endothelial dysfunction and is one of crucial factors in localizing early atherosclerosis .In contrary, normal and high shear stress is atheroma protective and is involved in compensatory remodeling . Most studies reported that the endothelial shear stress distribution in often idealized geometrical models of human coronary arteries was the subject of numerous investigations , and ...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Diagnosis of unstable angina and non-Q wave myocardial infarction
  • Age 18-75 yr.
  • Diameter stenosis of coronary artery\<70% diameter stenosis by visual estimation
  • Blood pressure \>110/70 mmHg
  • Heart rate 60-\~100 bpm, No cardiac arrhythmias
  • Exclusion Criteria:
  • St-elevation myocardial infarction
  • Lower blood pressure(\<100/70mmHg)
  • Heart rate \<60 or \>100 bpm, The presence of cardiac arrhythmias
  • Allergy to study drugs
  • Women in pregnancy
  • Liver dysfunction
  • Creatinine \>2.5mg/dl
  • Bleeding stroke within 6 months
  • Left ventricular ejection fraction\<30% before maximal medication

About Nanjing Medical University

Nanjing Medical University is a leading institution in medical education and research, dedicated to advancing health care through innovative clinical trials and scientific inquiry. With a strong emphasis on translating research findings into practical applications, the university fosters collaboration among multidisciplinary teams to address pressing health issues. Committed to ethical standards and patient safety, Nanjing Medical University is at the forefront of clinical research, contributing valuable insights and advancements in medical science to improve patient outcomes and enhance public health.

Locations

Nanjing, Jiangsu, China

Patients applied

0 patients applied

Trial Officials

Shao-liang Chen, Director

Study Chair

Nanjing First Hospital, Nanjing Medical University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials